drugset / Trial / NCT02678520

Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients

NCT02678520

RandomizedParallel-groupOpen-label

Summary

Compare the incidence of acute rectal, bladder and other acute toxicities between 3-D Conformal Radiation Therapy (RT/CRT) and Intensity Modulated Radiation Therapy (IMRT) in Post-Prostatectomy Prostate Cancer Patients treated with post-operative radiation therapy

Timeline

Start
2015-12
Primary completion
2016-02
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Background Bicalutamide Other / unclassified 50 mg Oral
Background Goserelin Other / unclassified 10.8 mg Subcutaneous
Background Leuprolide Other / unclassified 7.5 mg Intramuscular
Background Leuprolide Other / unclassified 22.5 mg Intramuscular

Indications